Barakat, R., Farghaly, A., El-Masry, A. G., El-Sayed, M., Husein, M. H. and Miller, F. D. (1995). Schistosoma mansoni in the Nile Delta, Egypt. A large scale epidemiological study in Kafr El Sheik Governorate. Tropical and Geographical Medicine 47, 259–265.
Berhe, N., Gunderson, S., Abebe, F., Birrie, H., Medhin, G. and Gemetchu, T. (1999). Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia. Acta Tropica 72, 53–63.
Botros, S., Sayed, H., Amer, N., El Ghannam, M., Bennett, J. L. and Day, T. A. (2005). Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. International Journal for Parasitology 35, 787–791.
Brindley, P. J. and Sher, A. (1987). The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. Journal of Immunology 139, 701–706.
Chitsulo, L., Engels, D., Montresor, A. and Savioli, L. (2000). The global status of schistosomiasis and its control. Acta Tropica 77, 41–51.
Clegg, J. A. (1965). In vitro cultivation of Schistosoma mansoni. Experimental Parasitology 16, 133–147.
Danso-Appiah, A. and De Vlas, S. J. (2002). Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends in Parasitology 18, 125–129.
Davis, A. C. (1993). Antischistosomal drugs and clinical practice. In Human Schistosomiasis (ed. Joidan, P.Webbe, G. and Sturrock, R. F.), pp. 367–404. CAB International, Oxford, UK.
Engels, D., Sinzinkayo, E. and Gryseels, B. (1996). Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications. American Journal of Tropical Medicine and Hygiene 54, 319–324.
Fenwick, A., Savioli, L., Engels, D., Bergquist, N. and Todd, M. (2003). Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends in Parasitology 19, 509–515.
Gryseels, B., Mbaye, A., De Vlas, S. J., Stelma, F. F., Guisse, F., Van Lieshout, L., Faye, D., Diop, M., Ly, A., Tchuem-Tchuente, L. A., Engels, D. and Polman, K. (2001). Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health 6, 864–873.
Gryseels, B., Nkulikyinka, L. and Coosemans, M. H. (1987). Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 641–644.
Gryseels, B., Stelma, F. F., Talla, I., Van Dam, G. I., Polman, K., Sow, S., Diaw, M. and Sturrock, R. (1994). Epidemiology, immunology and chemotherapy of Schistosoma mansoni infection in a recently exposed community in Senegal. Tropical and Geographical Medicine 46, 209–219.
Ismail, M., Botros, S., Metwally, A., William, S., Farghaly, A., Tao, L. F., Day, T. A. and Bennett, J. L. (1999). Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers. American Journal of Tropical Medicine and Hygiene 60, 932–935.
Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L. F. and Benett, J. (1996). Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. American Journal of Tropical Medicine and Hygiene 55, 214–218.
King, C. (2007). Quantification of disease burden due to schistosomiasis.TDR/SWG/07. World Health Organization, Geneva, Switzerland.
King, C., Dickman, K. and Tisch, D. (2005). Re-assessment of the cost of chronic helminthic infections: A meta-analysis. The Lancet 365, 1561.
Kumar, V. and Gryseels, B. (1994). Use of praziquantel against schistosomiasis: a review of the current status. International Journal of Antimicrobial Agents 4, 313–320.
Midzi, N., Sangweme, D., Zinyowera, S., Mapingure, M. P., Brouwer, K. C., Kumar, N., Mutapi, F., Woelk, G. and Mduzola, T. (2008). Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 759–766.
Peters, P. A., El Alamy, M., Warren, M. and Mahmoud, A. A. (1980). Quick Kato smear for field quantitation of Schistosoma mansoni eggs. American Journal of Tropical Medicine and Hygiene 29, 217–219.
Picquet, M., Vercruysse, J., Shaw, D. J., Diop, M. and Ly, A. (1998). Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 90–93.
Polderman, A. M., Gryseels, B. and De Caluwe, P. (1988). Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 115–116.
Raso, G., N'Goran, E., Totay, A., Luginbuhe, A., Adjoua, C. A., Tian-Bi, N. T., Bogoch, I. I., Vounatsou, P., Tanner, M. and Utzinger, J. (2004). Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d'Ivoire. Transactions of the Royal Society of Tropical Medicine and Hygiene 98, 18–27.
Renganathan, E. and Cioli, D. (1998). An international initiative on praziquantel use. Parasitology Today 14, 390–391.
Sabah, A. A., Fletcher, C., Webbe, G. and Doenhof, M. (1986). Schistosoma mansoni chemotherapy of infections of different ages. Experimental Parasitology 61, 294–303.
Simonen, P. E., Nega, A. and Furu, P. (1990). Intestinal schistosomiasis among children in a labour village of Wonji Sugar Estate, Ethiopia. East African Medical Journal 67, 532–538.
Stelma, F. F., Talla, I., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A. N. and Gryseels, B. (1994). Efficacy and side effects of praziquantel in an endemic focus of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene 53, 167–170.
Utzinger, J., Keiser, J., Shuhua, X., Tanner, M. and Singer, B. H. (2003). Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrobial Agents and Chemotherapy 47, 1487–1495.
Utzinger, J., N'Goran, E., N'Dri, A., Lengler, C. and Tanner, M. (2000). Efficacy of praziquantel against Schistosoma mansoni with particular consideration of intensity of infection. Tropical Medicine and International Health 5, 771–778.
Van Lieshout, L., Stelma, F. F., Guisse, F., Falcao Ferreira, S. T., Polman, K., Van Dam, G., Diakhte, M., Sow, S., Deelder, A. A. M. and Gryseels, B. (1999). The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal. American Journal of Tropical Medicine and Hygiene 61, 760–765.
World Health Organization (1985). The control of schistosomiasis.Technical Report Series No. 728. World Health Organization, Geneva, Switzerland.
Xiao, S. H., Catto, B. A. and Webester, L. T. (1985). Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Diseases 151, 1130–1137.